非酒精性脂肪性肝病组织学评估的可靠性及扩展型NAFLD活动度评分的开发
四位肝脏病理学家经标准化培训后,对40例涵盖NAFLD全谱的肝活检进行两次盲法评分。结果显示评分者内信度ICC为0.80-0.85,评分者间信度ICC为0.60-0.72;肝细胞气球样变和Mallory-Denk小体与疾病活动度相关性最强,被用于构建扩展型NAFLD活动度评分(评分者内ICC 0.90,评分者间ICC 0.80)。结论认为需进一步验证包括反应性评估。
要点
- 现有组织学评分系统经培训后评分者内信度ICC为0.80-0.85,评分者间信度ICC为0.60-0.72。
- 肝细胞气球样变和Mallory-Denk小体与疾病活动度相关性最强,用于扩展型NAFLD活动度评分。
- 扩展型NAFLD活动度评分评分者内ICC为0.90,评分者间ICC为0.80。
核心结论
- 经过广泛准备后,经验丰富的病理学家对多种现有NAFLD组织学指标和纤维化分期系统的可靠性有所提高。
- 肝细胞气球样变和Mallory-Denk小体与疾病活动度相关性最强,被用于构建扩展型NAFLD活动度评分。
- 需进一步验证包括反应性评估。
研究设计与样本
- 四位参与先前RAND/UCLA研究的肝脏病理学家接受标准化培训和多次讨论,对40例代表NAFLD全谱的肝活检进行两次盲法评分,间隔≥2周。
主要发现
- 指数组内相关系数(ICC)估计显示评分者内信度为0.80-0.85,评分者间信度为0.60-0.72。
- 肝细胞气球样变项目的评分者间ICC为0.68-0.79,包括将评分从0-2扩展到0-4的项目。
- 脂肪变 measures 的评分者间ICC为0.72-0.80,与疾病活动度相关性差。
- 与疾病活动度相关性最大的是肝细胞气球样变和Mallory-Denk小体,两者用于开发扩展型NAS(评分者内ICC 0.90;评分者间ICC 0.80)。
- 纤维化 measures 的ICC为0.70-0.87。
局限性
- 需进一步验证包括反应性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The NASH Clinical Research Network histologic scoring system, the gold-standard NASH histology assessment for clinical trials, has demonstrated intrarater and interrater variability. An expert panel in a previous systematic Research and Development/University of California Los Angeles (RAND/UCLA) study determined that existing histologic scoring systems do not fully capture NASH disease activity and fibrosis, and standardized definitions of histologic features are needed. We evaluated the reliability of existing and alternate histologic measures and their correlations with a disease activity visual analog scale to propose optimal components for an expanded NAFLD activity score (NAS). APPROACH AND RESULTS: Four liver pathologists who were involved in the prior RAND/UCLA study underwent standardized training and multiple discussions with the goal of improving agreement. They were blinded to clinical information and scored histologic measures twice, ≥2 weeks apart, for 40 liver biopsies representing the full spectrum of NAFLD. Index intraclass correlation coefficient (ICC) estimates demonstrated intrarater (0.80-0.85) and interrater (0.60-0.72) reliability. Hepatocyte ballooning items had similar interrater ICCs (0.68-0.79), including those extending scores from 0-2 to 0-4. Steatosis measures (interrater ICCs, 0.72-0.80) correlated poorly with disease activity. Correlations with disease activity were largest for hepatocyte ballooning and Mallory-Denk bodies (MDBs), with both used to develop the expanded NAS (intrarater ICC, 0.90; interrater ICC, 0.80). Fibrosis measures had ICCs of 0.70-0.87. CONCLUSIONS: After extensive preparation among a group of experienced pathologists, we demonstrated improved reliability of multiple existing histologic NAFLD indices and fibrosis staging systems. Hepatocyte ballooning and MDBs most strongly correlated with disease activity and were used for the expanded NAS. Further validation including evaluation of responsiveness is required.
引用
- Pai RK, Jairath V, Hogan M, et al. Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score. Hepatology. 2022. PMID: 35332569. doi:10.1002/hep.32475
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。